- B2B
- Pharma & life sciences
- Has in-house R&D
About Apmonia Therapeutics
Biotechnology company specializing in developing anti-cancer immunotherapy targeting tumors with high levels of TSP-1 protein using proprietary peptide therapy and companion diagnostic kit
Key facts
- Industry
- Biotechnology
- Company size
- 11–50 employees
- Headquarters
- reims, grand est, France
- Founded
- 2019
- Revenue
- €4.6M – €36.5MTamtam estimate
- Website
- apmonia-therapeutics.com
Who should you contact at Apmonia Therapeutics?
Connect to Tamtam to see the decision-makers at Apmonia Therapeutics, with verified emails and phone numbers, and find more companies like it.
See who to contact, freeApmonia Therapeutics at a glance
Apmonia Therapeutics is a B2B company in the Biotechnology industry, headquartered in reims, grand est, France.
Apmonia Therapeutics was founded in 2019.
Apmonia Therapeutics has 11–50 employees.
Apmonia Therapeutics's revenue is €4.6M – €36.5M (Tamtam estimate).
Frequently asked questions about Apmonia Therapeutics
What is Apmonia Therapeutics's revenue?
Tamtam estimates Apmonia Therapeutics's annual revenue at €4.6M – €36.5M.
How many employees does Apmonia Therapeutics have?
Apmonia Therapeutics has 11–50 employees.
Where is Apmonia Therapeutics headquartered?
Apmonia Therapeutics is headquartered in reims, grand est, France.
Selling to companies like Apmonia Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies